贝莱德减持荣昌生物18.55万股 每股作价约81.64港元
Zhi Tong Cai Jing·2025-11-28 12:21

Group 1 - BlackRock reduced its stake in Rongchang Biologics (09995) by 185,500 shares at a price of HKD 81.6411 per share, totaling approximately HKD 15.1444 million [1] - After the reduction, BlackRock's remaining shareholding is approximately 10.4111 million shares, representing a stake of 4.99% [1]

REMEGEN-贝莱德减持荣昌生物18.55万股 每股作价约81.64港元 - Reportify